Published in J Virol on May 01, 2013
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev (1994) 8.92
Heterogeneity of the human papillomavirus group. J Virol (1989) 4.90
A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (1995) 4.40
Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature (2012) 4.35
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene (2000) 3.14
The p400 complex is an essential E1A transformation target. Cell (2001) 3.05
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40
The human papillomavirus E7 oncoprotein. Virology (2008) 2.32
Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev (2000) 2.01
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog (1999) 1.95
Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet (1998) 1.78
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res (1998) 1.75
Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res (1979) 1.73
The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology (2008) 1.65
E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol (2008) 1.54
Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol (2008) 1.53
Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene (1989) 1.40
How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. Virology (2009) 1.33
Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol (1984) 1.28
Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J Virol (2012) 1.28
Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling. Oncogene (2012) 1.27
Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene (2008) 1.22
Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res (2003) 1.20
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology (1991) 1.18
The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene (2003) 1.15
Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp (1986) 1.15
Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene (2001) 1.13
Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog (2011) 1.10
Human papillomaviruses and skin cancer. Semin Cancer Biol (1992) 1.09
Modulation of transformation of primary epithelial cells by the second exon of the Ad5 E1A12S gene. Oncogene (1991) 1.07
Interaction of the E1A oncoprotein with Yak1p, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases. Mol Biol Cell (2001) 1.03
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis. J Virol (2007) 0.93
Opposing oncogenic activities of small DNA tumor virus transforming proteins. Trends Microbiol (2011) 0.86
Efficient gene transfer into human monocyte-derived macrophages using defective lentiviral vectors. Cell Mol Biol (Noisy-le-grand) (2003) 0.84
The C terminus of E1A regulates tumor progression and epithelial cell differentiation. Virology (1998) 0.81
Complications of gamma knife surgery for Parkinson disease. Arch Neurol (2001) 3.97
Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell (1994) 3.86
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J (1995) 3.70
A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh (2007) 3.45
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene (1995) 2.89
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res (1989) 2.72
Physical mapping of a large-plaque mutation of adenovirus type 2. J Virol (1979) 2.50
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1991) 2.17
BH3-only proteins in apoptosis and beyond: an overview. Oncogene (2008) 2.13
Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology (1996) 2.12
Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem (1998) 2.06
Adenovirus 2 Ip+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation. Cell (1983) 2.01
Breaking down silos: the future of sexual and reproductive health care--an opinion from the women's health expert panel of the American Academy of Nursing. J Am Assoc Nurse Pract (2014) 1.99
Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem (1998) 1.81
Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product. Nucleic Acids Res (1991) 1.63
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem (1999) 1.57
Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol (2007) 1.49
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology (1990) 1.48
19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J Biol Chem (1984) 1.47
A unique pattern of integrated viral genes in hamster cells transformed by highly oncogenic human adenovirus 12. Cell (1976) 1.45
Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology (1994) 1.42
An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor. Oncogene (1988) 1.41
Enhanced infectivity of adenovirus type 2 DNA and a DNA-protein complex. J Virol (1978) 1.40
Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene (1989) 1.40
Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP. FEBS Lett (2003) 1.38
Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res (1999) 1.35
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene (2008) 1.32
Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes. Genes Dev (1987) 1.30
Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) (1996) 1.30
Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.28
Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation. Proc Natl Acad Sci U S A (1985) 1.27
Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol (1992) 1.25
Relationship between the transforming and transcriptional regulatory functions of adenovirus 2 E1a oncogene. Virology (1987) 1.24
Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation. EMBO J (1991) 1.24
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol (1993) 1.24
BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene (2008) 1.23
p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ (1995) 1.23
BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene (2007) 1.22
Pre-early polypeptides of bacteriophages T5 and BF23. J Virol (1977) 1.21
Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene (1998) 1.17
Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J Biol Chem (2005) 1.17
Structural determinants present in the C-terminal binding protein binding site of adenovirus early region 1A proteins. J Biol Chem (1998) 1.17
Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett (2003) 1.16
Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res (2002) 1.16
Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev. Virology (1990) 1.15
Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera. J Clin Microbiol (1977) 1.15
Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol (2006) 1.14
Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology (1990) 1.13
Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J Biol Chem (1999) 1.12
bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res (1996) 1.11
mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. J Virol (1976) 1.11
Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene (1996) 1.10
BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res (1999) 1.09
Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis. J Biol Chem (2000) 1.08
Requirement of a phage-induced 5'-exonuclease for the expression of late genes of bacteriophage T5. Proc Natl Acad Sci U S A (1973) 1.08
Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol (2001) 1.03
The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain. Mol Cancer Ther (2001) 1.01
Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen. J Virol (1984) 1.01
Colorimetric determination of patulin produced by Penicillium patulum. J Assoc Off Anal Chem (1982) 1.00
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl (2003) 0.98
Dual role of gene D5 in the development of bacteriophage T5. Nature (1974) 0.98
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J Biol Chem (1997) 0.97
The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. J Virol (1993) 0.97
Activation of the adenovirus 2 protein IX promoter by DNA replication in a transient expression assay. Nucleic Acids Res (1987) 0.97
Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia (2000) 0.97
Hinf family: a novel repeated DNA family of the human genome. Nature (1983) 0.96
Transforming genes among three different oncogenic subgroups of human adenoviruses have similar replicative functions. J Virol (1981) 0.95
Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant. Proc Natl Acad Sci U S A (1990) 0.95
Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene (2006) 0.95
Regulation of apoptosis by a Caenorhabditis elegans BNIP3 homolog. Oncogene (1998) 0.94
Regulation of expression of late genes of bacteriophage T5. J Virol (1974) 0.94
Changes in C-terminal binding protein 2 (CtBP2) corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2. J Biol Chem (2006) 0.94